Dov A. Goldstein

Insider Reports History

Entity
Individual
Signature
/s/ Dov A. Goldstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dov A. Goldstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Director Stock Option (right to buy) 15K $87.9K $5.86 Jun 24, 2024 Direct
NeuBase Therapeutics, Inc. Director Stock option (right to buy) 37.6K Sep 9, 2022 Direct
BioAge Labs, Inc. Chief Financial Officer Common Stock 22.4K Sep 25, 2024 Direct
Coya Therapeutics, Inc. Director Stock Option (right to buy) 5K Jan 1, 2024 Direct

Insider Reports Filed by Dov A. Goldstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BIOA BioAge Labs, Inc. Sep 25, 2024 0 $0 3 Sep 25, 2024 Chief Financial Officer
GANX Gain Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 Director
COYA Coya Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 19, 2024 Director
GANX Gain Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
COYA Coya Therapeutics, Inc. Jan 3, 2023 2 $0 4 Jan 4, 2023 Director
COYA Coya Therapeutics, Inc. Dec 28, 2022 0 $0 3 Dec 28, 2022 Director
GANX Gain Therapeutics, Inc. Sep 20, 2022 1 $0 4 Sep 22, 2022 Director
NBSE NeuBase Therapeutics, Inc. Sep 9, 2022 1 $0 4 Sep 12, 2022 Director
NBSE NeuBase Therapeutics, Inc. Aug 19, 2021 1 $0 4 Sep 17, 2021 Director
NBSE NeuBase Therapeutics, Inc. Jun 18, 2021 1 $38K 4 Jun 21, 2021 Director